These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38961380)

  • 41. Integrating ion mobility and imaging mass spectrometry for comprehensive analysis of biological tissues: A brief review and perspective.
    Rivera ES; Djambazova KV; Neumann EK; Caprioli RM; Spraggins JM
    J Mass Spectrom; 2020 Dec; 55(12):e4614. PubMed ID: 32955134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides.
    Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H
    Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topologies of amyloidogenic proteins in Congo red-positive sliced sections of formalin-fixed paraffin embedded tissues by MALDI-MS imaging coupled with on-tissue tryptic digestion.
    Nakanishi T; Ito M; Nirasawa T; Tsuji M; Takubo T
    Clin Biochem; 2013 Oct; 46(15):1595-600. PubMed ID: 23732480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
    Paueksakon P; Fogo AB; Sethi S
    Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ isobaric lipid mapping by MALDI-ion mobility separation-mass spectrometry imaging.
    Fu T; Oetjen J; Chapelle M; Verdu A; Szesny M; Chaumot A; Degli-Esposti D; Geffard O; Clément Y; Salvador A; Ayciriex S
    J Mass Spectrom; 2020 Sep; 55(9):e4531. PubMed ID: 32567158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of paralytic shellfish toxins using high-field asymmetric waveform ion mobility spectrometry with liquid chromatography-mass spectrometry.
    Beach DG; Melanson JE; Purves RW
    Anal Bioanal Chem; 2015 Mar; 407(9):2473-84. PubMed ID: 25619987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing Peak Capacity in Nontargeted Omics Applications by Combining Full Scan Field Asymmetric Waveform Ion Mobility Spectrometry with Liquid Chromatography-Mass Spectrometry.
    Arthur KL; Turner MA; Reynolds JC; Creaser CS
    Anal Chem; 2017 Mar; 89(6):3452-3459. PubMed ID: 28230966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-field asymmetric waveform ion mobility spectrometry coupled with liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-FAIMS-MS/MS) multi-component bioanalytical method development, performance evaluation and demonstration of the constancy of the compensation voltage with change of mobile phase composition or flow rate.
    Wu ST; Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2007; 21(22):3667-76. PubMed ID: 17939154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases.
    Tekin B; Gilani SI; Dasari S; Theis JD; Rech KL; Dao LN; Cubilla AL; Herrera Hernandez LP; Jimenez RE; Cheville JC; Dispenzieri A; Howard MT; McPhail ED; Erickson LA; Guo R; Gupta S
    Am J Clin Pathol; 2023 Sep; 160(3):303-313. PubMed ID: 37203248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strong positive light chain immunostaining in a patient with transthyretin amyloidosis.
    Chen J; Chen H; Zhou L; Liu D; Du F; Xiang H
    Hematology; 2023 Dec; 28(1):2244315. PubMed ID: 37551718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Online LC-FAIMS-MS/MS for the Analysis of Phosphorylation in Proteins.
    Zhao H; Creese AJ; Cooper HJ
    Methods Mol Biol; 2016; 1355():241-50. PubMed ID: 26584930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidimensional separation and analysis of alpha-1-acid glycoprotein N-glycopeptides using high-field asymmetric waveform ion mobility spectrometry (FAIMS) and nano-liquid chromatography tandem mass spectrometry.
    Chandler KB; Marrero Roche DE; Sackstein R
    Anal Bioanal Chem; 2023 Jan; 415(3):379-390. PubMed ID: 36401639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass spectrometry imaging protocol for spatial mapping of lipids, N-glycans and peptides in murine lung tissue.
    Ngai YT; Briggs MT; Mittal P; Young C; Parkinson-Lawrence E; Klingler-Hoffmann M; Orgeig S; Hoffmann P
    Rapid Commun Mass Spectrom; 2024 May; 38(9):e9721. PubMed ID: 38525810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved Thyreostatic Drug Detection in Animal Tissues Using Liquid Chromatography-High-Field Asymmetric Waveform Ion Mobility Spectrometry-Mass Spectrometry.
    Purves RW; Souster K; West M; Huda AM; Fisher CME; Belford MW; Shurmer BO
    J Agric Food Chem; 2022 Apr; 70(16):4785-4791. PubMed ID: 35060701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insight into the Protein Composition of Immunoglobulin Light Chain Deposits of Eyelid, Orbital and Conjunctival Amyloidosis.
    Nielsen NS; Poulsen ET; Klintworth GK; Enghild JJ
    J Proteomics Bioinform; 2014; Suppl 8():. PubMed ID: 26500418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of deposited peptides in amyloid lesions of AL amyloidosis by mass spectrometry].
    Sugimoto T; Tasaki M; Yamashita T; Ueda M; Ando Y; Obayashi K; Okuno Y; Hata H
    Rinsho Ketsueki; 2017; 58(6):589-594. PubMed ID: 28679987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.
    Noborn F; Thomsen C; Vorontsov E; Bobbio E; Sihlbom C; Nilsson J; Polte CL; Bollano E; Vukusic K; Sandstedt J; Dellgren G; Karason K; Oldfors A; Larson G
    Amyloid; 2023 Mar; 30(1):96-108. PubMed ID: 36209425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.